Drug-Drug Interaction of SHR1459 With a Strong CYP3A Index Inducer (Rifampicin)

NCT04649723 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects, Drug-drug Interaction, Pharmacokinetics, SHR1459

Interventions

DRUG: Rifampin
DRUG: SHR1459

Sponsor

Jiangsu HengRui Medicine Co., Ltd.